TXNDC15

TXNDC15 (TMX5) is an ER-resident thioredoxin-related transmembrane member of the protein disulfide isomerase (PDI) family that links redox-dependent disulfide chemistry to protein quality control, secretory trafficking, and ciliary signaling (PMID:39348940). It functions as a natural "trapping mutant" within the PDI family, using its active-site cysteine C220 to covalently engage a subset of single- and multipass Golgi-resident secretory proteins (PMID:39348940). TXNDC15 lacks its own ER retention signal and instead achieves its ER/pre-Golgi localization through engagement of ERp44, a mixed disulfide forming between the catalytic cysteine of ERp44 and the non-catalytic cysteines C114/C124 of TXNDC15; it also associates with PDI and ERp57 (PMID:39348940). Beyond substrate trapping, TXNDC15 is an essential, catalysis-independent factor in MARCHF6-mediated ER-associated degradation, where its loss impairs substrate (ABHD2) exit and degradation and remodels the ER proteome and lipid homeostasis (PMID:41959069). In cilia biology, its thioredoxin domain is required—acting from outside the transition zone—for assembly of the MKS module and proper gating of ciliary membrane proteins, with both disease-associated thioredoxin-domain variants and cysteine mutations failing to rescue knockout defects (PMID:39679447). A frameshift knock-in mouse fully recapitulates Meckel-Gruber syndrome, establishing TXNDC15 as a bona fide MKS disease gene (PMID:41518077).

1. 2024 Medium

   Defining how an active-site PDI-family cysteine engages secretory cargo answered whether TXNDC15 acts catalytically or as a trap, establishing it as a covalent substrate-capturing oxidoreductase.

   Evidence Biochemical covalent trapping and co-IP with active-site cysteine mutants identifying Golgi-resident substrates

   PMID:39348940

   Open questions at the time

   • Substrate release/turnover mechanism not resolved
   • Physiological consequence of trapping individual substrates not established
   • Single lab
2. 2024 Medium

   Mapping the precise cysteines mediating ERp44 binding answered how a retention-signal-less protein is localized, showing TXNDC15 distribution is enforced by a mixed-disulfide handoff rather than an intrinsic motif.

   Evidence Co-IP plus active-site and non-catalytic cysteine mutagenesis and subcellular localization assays

   PMID:39348940

   Open questions at the time

   • Dynamics of ERp44 cycling not characterized
   • Whether PDI/ERp57 associations are functional or incidental unclear
   • Single lab
3. 2024 Medium

   Linking TXNDC15 thioredoxin-domain integrity to transition-zone assembly answered how a disease gene contributes to ciliogenesis, showing it controls MKS module assembly and ciliary membrane gating remotely via redox-relevant cysteines.

   Evidence Knockout cells with wild-type, disease-variant, and cysteine-mutant rescue and immunofluorescence of TZ and ciliary membrane components

   PMID:39679447

   Open questions at the time

   • Direct ciliary substrate(s) of TXNDC15 not identified
   • Mechanism connecting ER-located activity to transition-zone integrity unresolved
   • Single lab
4. 2026 Medium

   Identifying TXNDC15 as essential for MARCHF6-dependent ERAD answered whether its quality-control role requires catalysis, showing a catalysis-independent function in substrate exit and degradation that also shapes ER lipid homeostasis.

   Evidence Genome-wide CRISPR screen, KO validation, catalytic mutant rescue, ER proteomics and lipidomics (preprint)

   PMID:41959069

   Open questions at the time

   • Molecular basis of catalysis-independent ERAD support unknown
   • Whether TXNDC15 directly contacts MARCHF6 not shown
   • Preprint, single lab
5. 2026 High

   An in vivo frameshift model answered whether loss of TXNDC15 is causal for Meckel-Gruber syndrome, confirming complete phenotype recapitulation and disease-gene status.

   Evidence CRISPR-Cas9 knock-in mouse, E15.5 embryo phenotyping, tissue Western blot for TXNDC15

   PMID:41518077

   Open questions at the time

   • Cell-type-specific contribution to each malformation not dissected
   • Link between molecular redox/ERAD function and organ phenotypes not mechanistically traced
6. 2026 Low

   A reported TXNDC15-NEK4 interaction raised a potential cell-cycle/tumor-suppressive role, implicating TXNDC15 in G2/M checkpoint control in lung adenocarcinoma.

   Evidence Co-IP and loss-of-function cell cycle analysis

   PMID:42214920

   Open questions at the time

   • Single Co-IP without reciprocal validation or interaction-interface mapping
   • No structural or mutagenesis confirmation
   • Mechanism linking an ER oxidoreductase to mitotic NEK4 unexplained

• How TXNDC15's ER redox/ERAD activities mechanistically produce its ciliary transition-zone and developmental functions remains unresolved.
• No unifying mechanism connecting ER-localized disulfide chemistry to transition-zone assembly
• Direct ciliary and ERAD substrates incompletely defined
• Structural basis of substrate/partner engagement unknown